Dietary omega-3 fatty acids in the management of feline periodontal disease: What is the evidence?

J Anim Physiol Anim Nutr (Berl). 2023 Nov;107(6):1465-1472. doi: 10.1111/jpn.13855. Epub 2023 Jul 4.

Abstract

Periodontal disease is an oral disorder with high prevalence in cats from 2 years of age, resulting from an inflammatory response against bacterial plaque. Treatment depends on the stage of the disease and may include dental scaling, local application of perioceutics, tissue regeneration and/or even tooth extraction and periodontal surgery. As multimodal therapy is often required, new strategies have been developed to improve the therapeutic response in these patients. Adjuvant use of omega-3 fatty acids has been reported in humans with periodontal disease, but the current evidence of its effect in companion animals, especially cats, is still considered to be scarce and conflicting. This review describes the state of the art regarding feline periodontal disease and seeks to clarify the potential effect of omega-3 fatty acids on its clinical management in light of the evidence available in the current literature.

Keywords: DHA; EPA; cats; omega-3 fatty acids; periodontal disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Cat Diseases* / drug therapy
  • Cats
  • Diet / veterinary
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid
  • Fatty Acids, Omega-3*
  • Humans
  • Periodontal Diseases* / drug therapy
  • Periodontal Diseases* / prevention & control
  • Periodontal Diseases* / veterinary

Substances

  • Eicosapentaenoic Acid
  • Fatty Acids, Omega-3
  • Docosahexaenoic Acids